Stem Cell Global Market Report 2025

Description

Stem cells, whether autologous or allogenic, possess the ability to differentiate into various cell types both in vivo and in vitro, making them valuable in the medical treatment of injuries and organ damage.

The primary product categories of stem cells include adult stem cells, human embryonic stem cells, induced pluripotent stem cells, and others. Adult stem cells represent a rare cell population in the body during the majority of postnatal life, capable of giving rise to a limited number of mature cell types that contribute to the formation of the tissue in which they are located. These stem cells can be derived from autologous or allogeneic sources and find applications in diverse areas such as regenerative medicine, drug discovery, and development.

The stem cell market research report is one of a series of new reports from The Business Research Company that provides stem cell market statistics, including stem cell market industry global market size, regional shares, competitors with a stem cell market share, detailed stem cell market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell market industry. This stem cell market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell market size has grown strongly in recent years. It will grow from $15.34 billion in 2024 to $16.85 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to advancements in regenerative medicine, growing prevalence of chronic diseases, research and development initiatives, increasing aging population, rising awareness and acceptance.

The stem cell market size is expected to see rapid growth in the next few years. It will grow to $25.92 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to expanding applications in oncology, innovations in personalized medicine, government support and funding, biotechnology collaborations and partnerships, clinical trials and regulatory approvals. Major trends in the forecast period include commercialization of stem cell therapies, application of CRISPR technology, regulatory framework development, investments in stem cell research, focus on exosome therapeutics.

The rising prevalence of chronic diseases worldwide is fueling growth in the stem cell market. Stem cell therapy involves using stem cells to treat or prevent various diseases and conditions. While bone marrow transplants are the most widely utilized form of stem cell therapy, treatments derived from umbilical cord blood are also becoming increasingly common. Currently, the transplantation of blood stem cells is a prominent application, particularly for treating blood and immune system disorders or for restoring the blood system following cancer treatments. For instance, in April 2024, Allergy UK, a UK-based national charity, reported that over 21 million people in the UK are affected by allergies, making it the most commonly reported chronic health condition in 2022. Projections suggest that by 2026, half of Europe's population will experience at least one allergy. Therefore, the increasing prevalence of chronic diseases worldwide is driving the growth of the stem cell market.

The growth of the stem cell market is further fueled by the increasing demand for personalized medicine. Personalized medicine tailors medical treatment to an individual's unique genetic makeup, providing more precise and effective healthcare interventions. Stem cells, in the context of personalized medicine, offer the potential for regenerating and replacing damaged tissues, allowing for treatments tailored to individual patients. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% (12 of them) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Thus, the rising demand for personalized medicine contributes to the growth of the stem cell market.

Companies operating in the stem cell therapeutics market are concentrating on advancing technologies, such as Induced Pluripotent Stem Cells (IPSC), to enhance the effectiveness of stem cell therapies. IPSCs are derived from blood or skin cells that undergo reprogramming to achieve an embryonic-such as pluripotent state. This process involves the introduction of genes essential for maintaining key properties and promoting the growth of an unlimited source of any human cell type required for stem cell therapeutic purposes. Importantly, IPSCs are not derived from human embryos, addressing bioethical concerns and facilitating easier access to federal funding and support. An illustrative example is the Japanese company Oksara, which inaugurated a medicine center producing cells derived from IPSCs. Similarly, Takar Bio introduced human iPSC-derived Beta Cells, known as Cellartis, designed for disease modeling and drug discovery.

Major companies in the stem cell market are also prioritizing the development of automated stem cell analysis systems to gain a competitive advantage. These systems streamline the assessment of stem cell characteristics and viability, enhancing research and clinical applications with increased efficiency and precision. For instance, in May 2022, Beckman Coulter Inc., a US-based healthcare company, launched the AQUIOS STEM System, a solution specifically engineered for stem cell analysis. This system offers full automation, reducing hands-on time by 95% and minimizing error-prone tasks by 87.5%. Combining the automation capabilities of the AQUIOS CL with a stem cell enumeration solution, it can be customized to meet diverse requirements.

In April 2023, STEMCELL Technologies, a leading biotechnology firm based in Canada, acquired SQZ Biotechnologies Company for an undisclosed amount. This acquisition aims to strengthen STEMCELL's capabilities in delivering cell therapies by leveraging SQZ's innovative mechanoporation technology, which enables the introduction of therapeutic cargo into cells without the use of electricity. SQZ Biotechnologies, located in the United States, specializes in developing advanced methods for delivering therapeutic cargo into cells through this mechanoporation process. SQZ Biotechnologies Co. is recognized as a clinical-stage biotechnology company based in the U.S.

Major companies operating in the stem cell market include Danaher Corporation, Cryo-Cell International Inc., Daiichi Sankyo Company Limited, Lonza Group Ltd, PerkinElmer Inc., CellGenix GmbH, China Cord Blood Corporation, Organogenesis Holdings Inc., LifeCell International, Cord Blood America Inc., StemCyte Inc., Cryoviva India, Cordlife Group Limited, Thermo Fisher Scientific Inc., CordVida, Cryo Stemcell Inc., Pluristem Therapeutics Inc., Mesoblast Limited, Americord Registry LLC, Smart Cells International, Athersys Inc., ReeLabs Pvt. Ltd., Cytori Therapeutics Inc., Esperite N.V., Stemade Biotech, ViaCord, Aldagen Inc, Isto Biologics, Brainstorm Cell Therapeutics Inc.

North America was the largest region in the stem cell market in 2024. Western Europe was the second largest region in the global stem cell market share. The regions covered in the stem cell market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the stem cell market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The stem cell market consists of sales of organoids & 3D Cell Culture, mesenchymal Stem Cells, neural stem cells, hematopoietic stem cells, and cancer stem cells. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stem cell market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Source: Autologous; Allogeneic
2) By Product Type: Adult Stem Cell; Human Embryonic Stem Cell; Induced Pluripotent Stem Cell; Other Products
3) By Application: Regenerative Medicine; Drug Discovery And Development
Subsegments:
1) By Autologous: Bone Marrow-Derived Stem Cells; Adipose Tissue-Derived Stem Cells; Peripheral Blood Stem Cells
2) By Allogeneic: Bone Marrow-Derived Stem Cells; Umbilical Cord Blood Stem Cells; Peripheral Blood Stem Cells From Donors
Companies Mentioned: Danaher Corporation; Cryo-Cell International Inc.; Daiichi Sankyo Company Limited; Lonza Group Ltd; PerkinElmer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33024

1. Executive Summary

2. Stem Cell Market Characteristics

3. Stem Cell Market Trends And Strategies

4. Stem Cell Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Stem Cell Growth Analysis And Strategic Analysis Framework

5.1. Global Stem Cell PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Stem Cell Market Growth Rate Analysis
5.4. Global Stem Cell Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Stem Cell Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Stem Cell Total Addressable Market (TAM)

6. Stem Cell Market Segmentation

6.1. Global Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous
Allogeneic
6.2. Global Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult Stem Cell
Human Embryonic Stem Cell
Induced Pluripotent Stem Cell
Other Products
6.3. Global Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Regenerative Medicine
Drug Discovery And Development
6.4. Global Stem Cell Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bone Marrow-Derived Stem Cells
Adipose Tissue-Derived Stem Cells
Peripheral Blood Stem Cells
6.5. Global Stem Cell Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bone Marrow-Derived Stem Cells
Umbilical Cord Blood Stem Cells
Peripheral Blood Stem Cells From Donor

7. Stem Cell Market Regional And Country Analysis

7.1. Global Stem Cell Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Stem Cell Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stem Cell Market

8.1. Asia-Pacific Stem Cell Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stem Cell Market

9.1. China Stem Cell Market Overview
9.2. China Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stem Cell Market

10.1. India Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stem Cell Market

11.1. Japan Stem Cell Market Overview
11.2. Japan Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stem Cell Market

12.1. Australia Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stem Cell Market

13.1. Indonesia Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stem Cell Market

14.1. South Korea Stem Cell Market Overview
14.2. South Korea Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stem Cell Market

15.1. Western Europe Stem Cell Market Overview
15.2. Western Europe Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stem Cell Market

16.1. UK Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stem Cell Market

17.1. Germany Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stem Cell Market

18.1. France Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stem Cell Market

19.1. Italy Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stem Cell Market

20.1. Spain Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stem Cell Market

21.1. Eastern Europe Stem Cell Market Overview
21.2. Eastern Europe Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stem Cell Market

22.1. Russia Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stem Cell Market

23.1. North America Stem Cell Market Overview
23.2. North America Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stem Cell Market

24.1. USA Stem Cell Market Overview
24.2. USA Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stem Cell Market

25.1. Canada Stem Cell Market Overview
25.2. Canada Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stem Cell Market

26.1. South America Stem Cell Market Overview
26.2. South America Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stem Cell Market

27.1. Brazil Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stem Cell Market

28.1. Middle East Stem Cell Market Overview
28.2. Middle East Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stem Cell Market

29.1. Africa Stem Cell Market Overview
29.2. Africa Stem Cell Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stem Cell Market Competitive Landscape And Company Profiles

30.1. Stem Cell Market Competitive Landscape
30.2. Stem Cell Market Company Profiles
- 30.2.1. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Cryo-Cell International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Lonza Group Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Stem Cell Market Other Major And Innovative Companies

31.1. CellGenix GmbH
31.2. China Cord Blood Corporation
31.3. Organogenesis Holdings Inc.
31.4. LifeCell International
31.5. Cord Blood America Inc.
31.6. StemCyte Inc.
31.7. Cryoviva India
31.8. Cordlife Group Limited
31.9. Thermo Fisher Scientific Inc.
31.10. CordVida
31.11. Cryo Stemcell Inc.
31.12. Pluristem Therapeutics Inc.
31.13. Mesoblast Limited
31.14. Americord Registry LLC
31.15. Smart Cells International

32. Global Stem Cell Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Market

34. Recent Developments In The Stem Cell Market

35. Stem Cell Market High Potential Countries, Segments and Strategies

35.1 Stem Cell Market In 2029 - Countries Offering Most New Opportunities
35.2 Stem Cell Market In 2029 - Segments Offering Most New Opportunities
35.3 Stem Cell Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer